Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Nose-to-brain delivery of transferrin-modified carmustine-loaded iron nanoparticles for enhanced glioblastoma treatment79
Polymyxin B delivery systems: smart solutions for improved antibacterial activity and reduced toxicity61
Advancement in transporter-oriented nanoplatforms for cancer therapy46
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma45
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances39
Post-transcriptional knockdown of BRCC3 via siRNA-loaded niosomes modulates autophagy and endoplasmic reticulum stress in rotenone-induced Parkinson’s Disease model38
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches33
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis32
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma31
Beyond drug delivery: nanoparticles as active modulators of immunometabolism for treating inflammatory diseases29
Chitosan–β-glycerophosphate thermogelling microneedles for transdermal contraceptive delivery of levonorgestrel29
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells29
Correction26
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer26
Improved antidiabetic potential of quercetin-loaded chitosan–lecithin nanoparticles for effective glycaemic control26
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases25
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes25
Emerging role of ferroptosis in diabetic retinopathy: a review25
Application of small interfering RNAs and drug combination for pancreatic cancer therapy24
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice23
Correction23
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer23
The role of MSC-derived exosomes in immune modulation and regenerative medicine23
0.19424915313721